Sardapharma SRL
Sardapharma reported total assets of 955,194 € at the end of the 2024 financial year (annual accounts filed with the NBB on 14 Nov 2025).
The score of Sardapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +22 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sardapharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 14 Nov 2025
- Year ended 31 Dec 2023filed on 06 Nov 2024
- Year ended 31 Dec 2022filed on 20 Nov 2023
- Year ended 31 Dec 2021filed on 06 Nov 2022
- Year ended 31 Dec 2020filed on 28 Sep 2021
Sardapharma's financial analysis
- Solvency24.9%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sardapharma
Sardapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.270.324
- VAT number
- BE0473270324
- Peppol
- Registered · 0208:0473270324 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Nov 2000
- Registered office
- 1000 Brussels
- Latest accounts
- 2024 · filed on 14 Nov 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sardapharma (SRL) has been based in Brussels since 2000, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 22,250 € and equity of 237,664 €; its revenue is not published. Its solvency stands at 24.9%, below the median of its sector (37.8%).
Companies similar to Sardapharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Wiers Retail sale of pharmaceutical products Péruwelz · balance sheet 953,598 €
- Apotheek Verstraete TIM Retail sale of pharmaceutical products Ternat · balance sheet 959,103 €
- LA-BO Retail sale of pharmaceutical products Londerzeel · balance sheet 947,559 €
- Smets Farma Retail sale of pharmaceutical products Antwerp · balance sheet 944,084 €
- Ramselpharma Retail sale of pharmaceutical products Herselt · balance sheet 941,066 €
- Sybephar Retail sale of pharmaceutical products Oudenaarde · balance sheet 970,416 €
- Medithera Retail sale of pharmaceutical products Rixensart · balance sheet 972,011 €
Frequently asked questions about Sardapharma
What is the revenue of Sardapharma?
Sardapharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Sardapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0473270324 for Sardapharma, if the company is VAT-registered. Its company number (CBE) is 0473.270.324.
Where is the registered office of Sardapharma?
According to the CBE register, the registered office of Sardapharma is in 1000 Brussels.
What is the equity of Sardapharma?
At the close of the 2024 financial year, the equity of Sardapharma amounts to 237,664 €, a solvency of 24.9% of total assets.
Who manages Sardapharma?
The register lists 1 active mandates at Sardapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sardapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →